Evidence map›Paper›PMID 26854234›Full record

ArticleCell reports2016

ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA.

Hui Zhang, PamelaSara E Head, Waaqo Daddacha, Seong-Hoon Park, Xingzhe Li, Yunfeng Pan, Matthew Z Madden, Duc M Duong, Maohua Xie, Bing Yu and 13 more

Abstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. A DNA damage-induced phosphorylation circuit enhances Mec1Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. DNA Damage-Mediated Neurotoxicity in Parkinson's Disease.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Molecular Link between DNA Damage Response and Microtubule Dynamics.International journal of molecular sciences · 2022
    Review
  19. Protocol forSTAR protocols · 2022
    Article
  20. Fueling genome maintenance: On the versatile roles of NADThe Journal of biological chemistry · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Hui ZhangDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
PamelaSara E HeadDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Waaqo DaddachaDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Seong-Hoon ParkDepartment of Radiation Oncology and Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Xingzhe LiDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Yunfeng PanDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Matthew Z MaddenDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Duc M DuongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Maohua XieDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Bing YuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Matthew D WarrenDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Elaine A LiuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Vishal R DhereDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Chunyang LiDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ivan PradillaDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Mylin A TorresDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ya WangDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
William S DynanDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Paul W DoetschDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Xingming DengDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
David GiusDepartment of Radiation Oncology and Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
David S YuDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: dsyu@emory.edu.

Funding

Mechanisms of SIRT2 Function in the Replication Stress ResponseR01CA178999 · NCI · EMORY UNIVERSITY · PI YU, DAVID SUNG-WEN · 2013 to 2023
$3.5M
Loss of mtSIRT3, Decreased MnSOD Activity, and IR Induced Genomic InstabilityR01CA152601 · NCI · VANDERBILT UNIVERSITY · PI BONINI, MARCELO G. · 2010 to 2019
$3.5M
Regulation of DNA Double-Strand Break RepairR01CA098239 · NCI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI DYNAN, WILLIAM S. · 2004 to 2013
$2.1M
ROS and HIFa as molecular targets for chemoprevention in Sirt3 -/- breast cancersR01CA168292 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GIUS, DAVID · 2012 to 2016
$1.9M
SIRT3 is a Mitochondrial Tumor Suppressor in ER/PR Positive Mammary TumorsR01CA152799 · NCI · VANDERBILT UNIVERSITY · PI GIUS, DAVID · 2011 to 2015
$1.6M
Role of CDK9 in the Replication Stress ResponseK08CA143902 · NCI · VANDERBILT UNIVERSITY · PI YU, DAVID SUNG-WEN · 2010 to 2014
$823k
NCI NIH HHS 1R01CA152799-01A1NCI NIH HHS 1R01CA16383801A1NCI NIH HHS 1R01CA168292-01A1NCI NIH HHS 2R01CA152601-06A1NCI NIH HHS K08 CA143902NCI NIH HHS K08CA143902NCI NIH HHS R01 CA098239NCI NIH HHS R01 CA152601NCI NIH HHS R01 CA178999NCI NIH HHS R01CA178999NCI NIH HHS R01CA178999S1NCI NIH HHS R01CA98239
6 · The paper itself

Abstract

The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase checkpoint pathway maintains genome integrity; however, the role of the sirtuin 2 (SIRT2) acetylome in regulating this pathway is not clear. We found that deacetylation of ATR-interacting protein (ATRIP), a regulatory partner of ATR, by SIRT2 potentiates the ATR checkpoint. SIRT2 interacts with and deacetylates ATRIP at lysine 32 (K32) in response to replication stress. SIRT2 deacetylation of ATRIP at K32 drives ATR autophosphorylation and signaling and facilitates DNA replication fork progression and recovery of stalled replication forks. K32 deacetylation by SIRT2 further promotes ATRIP accumulation to DNA damage sites and binding to replication protein A-coated single-stranded DNA (RPA-ssDNA). Collectively, these results support a model in which ATRIP deacetylation by SIRT2 promotes ATR-ATRIP binding to RPA-ssDNA to drive ATR activation and thus facilitate recovery from replication stress, outlining a mechanism by which the ATR checkpoint is regulated by SIRT2 through deacetylation.

Indexed as

DNA ReplicationAcetylationAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsCell Cycle CheckpointsCell Line, TumorDNA-Binding ProteinsDNA DamageDNA, Single-StrandedGene Expression RegulationHCT116 CellsHEK293 CellsHeLa CellsHumansPhosphorylationProtein BindingAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATRIP protein, humanATR protein, humanDNA-Binding ProteinsDNA, Single-StrandedReplication Protein ASIRT2 protein, humanSirtuin 2acetylomeATRATRIPcell cyclecheckpointDNA damage responseDNA repairDNA replicationmetabolismreplication stressSIRT2sirtuin

Identifiers

PMID26854234
PMCPMC4758896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.